CFFI
C&F Financial Corporation
CFFI trails on the overall score without a compensating advantage in the available component scores.
MS
Morgan Stanley
MS has the edge over CFFI overall, supported by stronger modeled upside and stronger valuation.
CFFI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CFFI's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CFFI.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CFFI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.3x | $58.98 | -44% |
| Fair | 7.3x | $68.48 | -35% |
| Expensive | 9.8x | $91.59 | -13% |
| Current | 11x | $106 | — |
Historical ranges are pointers, not guarantees.
CFFI has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CFFI Forward outlook
There aren't enough analyst estimates for CFFI to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
CFFI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.34 | +16% |
| Q2 2026 | $8.97 | +19% |
| Q1 2026 | $8.71 | +31% |
| Q4 2025 | $8.29 | +38% |
| Q3 2025 | $8.06 | +42% |
| Q2 2025 | $7.53 | +31% |
| Q1 2025 | $6.66 | +9.7% |
| Q4 2024 | $6.01 | -13% |
CFFI earned $9.34 per share over the past year, up 16% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over CFFI on earnings, with more consistent year-over-year improvement.
CFFI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $38.2M | +6.1% |
| Q2 2026 | $40.9M | +12% |
| Q1 2026 | $36.3M | +11% |
| Q4 2025 | $35.9M | +12% |
| Q3 2025 | $36M | +7.6% |
| Q2 2025 | $36.4M | +17% |
| Q1 2025 | $32.6M | +6.3% |
| Q4 2024 | $32.1M | -0.9% |
CFFI's revenue has grown year over year for seven quarters in a row: $38M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +2.1 points |
| Q2 2026 | 27% | +0.1 points |
| Q1 2026 | 23% | +3 points |
| Q4 2025 | 23% | 0 points |
| Q3 2025 | 25% | +4.6 points |
| Q2 2025 | 26% | +6.5 points |
| Q1 2025 | 20% | +7 points |
| Q4 2024 | 23% | +3.4 points |
CFFI's operating margin was 27% last quarter, up 2.1 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over CFFI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over CFFI on profitability, with a higher operating margin.
CFFI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.3M | +16% |
| Q2 2026 | $22.3M | +$27.2M |
| Q1 2026 | -$7.9M | -368% |
| Q4 2025 | $1.5M | -96% |
| Q3 2025 | $22.7M | +$24.3M |
| Q2 2025 | -$5M | -529% |
| Q1 2025 | $2.9M | +618% |
| Q4 2024 | $35.1M | +112% |
CFFI has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
CFFI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -745 shares |
| 1 year | +0.4% | +13.4K shares |
| 3 years | -4.1% | -140K shares |
| 5 years | -8.4% | -299K shares |
| Available history | -5.8% | -199K shares |
CFFI has 3M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $14,000 |
| Q2 2026 | $367,000 |
| Q1 2026 | $614,000 |
| Q4 2025 | $507,000 |
| Q3 2025 | — |
| Q2 2025 | $10,000 |
| Q1 2025 | $426,000 |
| Q4 2024 | $969,000 |
CFFI spent $2M buying back its own shares over the past year, up 6.9% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over CFFI on shareholder dilution, with a more favorable share count trend.
CFFI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 2.6x | Moderate |
CFFI has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
CFFI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.7 | Overbought |
| Stochastic | 77.1 | Neutral |
CFFI's weekly RSI is 71 (overbought) and its Stochastic is 77 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CFFI PE vs Financial Services Sector
| Metric | CFFI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 93 | 63 | 30 pts above |
CFFI has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
CFFI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.9 | 2.8% above |
| 20 week MA | $93.2 | 14% above |
| 50 week MA | $81.8 | 29% above |
| 100 week MA | $75.3 | 40% above |
| 200 week MA | $65.4 | 62% above |
CFFI has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
CFFI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $55.8 | $37.2 | -33% |
| 2021 | $37.2 | $52.1 | +40% |
| 2022 | $52.1 | $58.0 | +11% |
| 2023 | $58.0 | $68.2 | +18% |
| 2024 | $68.2 | $72.2 | +5.9% |
| 2025 | $72.2 | $71.2 | -1.4% |
| 2026 YTD | $71.2 | $105.8 | +49% |
CFFI has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.